Diabetes Care 35:252258 Knudsen LB, Nielsen PF, Huusfeldt PO et al (2000) Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
Alimentos como el brcoli, la espinaca y los aguacates pueden complementar la terapia, mejorando los resultados generales de salud.
Muscle loss, which is one of the biggest risks associated with GLP-1 use
Persistent nausea lasting more than 2 weeks after a dose increase warrants stepping back to the previous dose for 2 to 4 additional weeks before trying again
Roy N, Gaur A, Jain A, Bhattacharya S, Rani V: Green synthesis of silver nanoparticles: an approach to overcome toxicity
HansonEKalishLABunceECurtisCMcDanielSWareJet al